60Nd

www.60nd.bio ↗ ·Madrid ·Seed

60Nd is a deeptech spin-off of Universidad Carlos III de Madrid (UC3M) working in mechanobiology/mechanomedicine. It builds NeoMag, a portable device that combines magneto-active (magneto-intelligent) polymers with AI to apply programmable, non-invasive mechanical stimuli to 2D and 3D cell cultures, letting labs reproduce in vitro the mechanical conditions of pathologies such as tumours, brain trauma or tissue scarring. The company won a €2.4M EIC Transition grant under Horizon Europe (one of ~40 European deeptech projects selected), has raised over €3M in total including a ~€1.1M mix of private investment and public support (CDTI), and was a South Summit Madrid 2026 finalist in the Health category; its customers/users include UCL, Institut Pasteur, UCSF and CNIC.

Founded

2023

Founders

Total funds raised

€500K

Rounds

Last round

Mar 2026

SectorsHealthtech & Bio, Deeptech & Hardware, Biotech Instrumentation, Mechanobiology, AI & Data Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Daniel García González

Co-founder & Chief Scientific Officer (CSO)

Ricardo de la Torre González

Co-founder & CEO

Global models 3

Emulate

United States · emulatebio.com ↗

Sells instruments and consumables to pharma and research labs that recreate in vivo conditions, including mechanical forces, in human cell models for disease modelling and drug testing.

$225MComparable

CN Bio

United Kingdom · cn-bio.com ↗

Sells lab hardware (PhysioMimix) that recreates physiological conditions for 3D cell cultures in vitro, the same device-for-labs model as NeoMag applied through microfluidics.

$45MComparable

Curi Bio

United States · www.curibio.com ↗

Sells lab instruments and plates that stimulate engineered 3D human tissues and measure how they respond mechanically, the closest match to 60Nd's programmable mechanical-stimulation device.

$25MComparable